Progress in Mind Finland | Progress In Mind

Home

Parkinson's Disease

Congress highlights

Early detection, treatment and the potential for future prevention is the precursor of a new era in Parkinson’s disease

Detecting Parkinson’s disease (PD) early is essential so that therapy may be given as early...

Congress highlights

Tics and Tourette Syndrome: The spectrum of symptoms and treatments

The next 5 years could deliver answers to several burning questions regarding the management of...

Depression, Schizophrenia

Congress highlights

Potential new targets in depression and schizophrenia – learnings from obesity and exercise

Weight loss and exercise increase benefit for mental health, but are difficult to achieve....

Congress highlights

Lifestyle, the gut, and mental health

Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...

Congress highlights

Enhancing neuroimaging genetics – What do we really see?

Enhancing neuroimaging genetics through meta-analysis (ENIGMA) does exactly what its expanded...

Positive steps to address negative symptoms in schizophrenia

A goal of precision psychiatry is to locate a patient along the continuum of the disease course,...

Bipolar, Schizophrenia

Highlighted studies in psychosis

New light cast on links between mental illness and creativity; inflammatory pathways that may be...

Future of schizophrenia treatment: Where do we go now?

Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...

Does glutamate hold the key to unlocking major depressive disorder?

Despite over 50 years of drug development in major depressive disorder (MDD), patients and their...

Depression, Bipolar

Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders

Brain health is important to us all, and cognitive impairment causes significant morbidity....

Congress highlights

Treating cognitive symptoms improves workplace productivity

The new paradigm for the treatment of major depressive disorder (MDD) is to “make patients...

Congress highlights

Niche no more: early use of long-acting injectable antipsychotics in schizophrenia

It is well known that early treatment of schizophrenia leads to better patient outcomes in the long...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Finland
HCP Access verification required

To gain access, please login with your Fimnet ID.

Login

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The website is created by Lundbeck Finland for Finland healthcare professionals only.

Accept

Decline